This fertility benefit business is set to boom. Buy its stock now, Wells Fargo says
Progyny is set to benefit from several structural tailwinds, including catalysts that should help it court more clients, according to Wells Fargo.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.